- Learn
- Presentations
- Postmenopausal bleeding
Postmenopausal bleeding
Gynaecology
Clinic, referred promptly
The first question
Is this endometrial cancer, until proven otherwise?
- 01
Confirm
Bleeding a year or more after the last period, or unscheduled bleeding on hormone therapy; separate from urinary or rectal bleeding.
- 02
Examine
Vulva, vagina, cervix on speculum; screening if due; bimanual.
- 03
Transvaginal ultrasound
Endometrial thickness: 4 mm or less makes cancer unlikely; more, or persistent bleeding, means sampling.
- 04
Sample
Office endometrial biopsy; hysteroscopy with biopsy if inadequate, if a polyp is seen, or if bleeding persists.
Where it is
Each opens the structure on the 3D pelvis.
History that discriminates
- Amount and pattern, time since menopause
- Hormone therapy and its regimen, tamoxifen
- Obesity, diabetes, hypertension, nulliparity, PCOS history
- Family history of endometrial, colorectal or ovarian cancer (Lynch)
- Anticoagulants
- Vaginal dryness, dyspareunia
Examination that discriminates
- Vulva and vagina: atrophy, lesions
- Speculum: cervix, polyps, contact bleeding, source
- Bimanual: uterine size, adnexal masses
Investigations
- Transvaginal ultrasound
- Endometrial biopsy
- Hysteroscopy
- Cervical screening if due
- CBC
The differential
| Diagnosis | Favours | Against | Urgency |
|---|---|---|---|
| Endometrial cancer or hyperplasia | Thickened endometrium, risk factors, persistent bleeding | Thin endometrium and a single episode | urgent |
| Atrophic endometrium or vaginitis | Thin endometrium, atrophic vagina, light spotting | Thickened endometrium | routine |
| Endometrial or cervical polyp | Polyp on scan or speculum | None seen | routine |
| Hormone therapy bleeding | Expected withdrawal on a cyclical regimen; early months of a continuous one | Bleeding after the first 6 months of continuous therapy, or heavy | routine |
| Cervical cancer | Visible lesion, postcoital bleeding, no screening history | Normal cervix and screening | urgent |
| Vulvar or vaginal lesion | Visible lesion | Normal examination | urgent |
Pitfalls this pathway refuses
- Attributing bleeding to atrophy without a scan
- Stopping after a thin endometrium when bleeding recurs
- Not examining the vulva and cervix